These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

526 related articles for article (PubMed ID: 33788036)

  • 41. Presentation of new onset anosmia during the COVID-19 pandemic.
    Hopkins C; Surda P; Kumar N
    Rhinology; 2020 Jun; 58(3):295-298. PubMed ID: 32277751
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [From pathophysiology to therapeutic management of loss of smell in Covid-19].
    Nguyen DT; Masson V; Jankowski R; Toussaint B; Gallet P; Rumeau C; Chenuel B
    Rev Prat; 2021 Jan; 71(1):13-19. PubMed ID: 34160932
    [No Abstract]   [Full Text] [Related]  

  • 43. [Smell impairment in COVID-19 patients: mechanisms and clinical significance].
    Kryukov AI; Kazakova AA; Hecht AB
    Vestn Otorinolaringol; 2020; 85(5):93-97. PubMed ID: 33140943
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chemosensory dysfunction in COVID-19 out-patients.
    Rojas-Lechuga MJ; Izquierdo-Domínguez A; Chiesa-Estomba C; Calvo-Henríquez C; Villarreal IM; Cuesta-Chasco G; Bernal-Sprekelsen M; Mullol J; Alobid I
    Eur Arch Otorhinolaryngol; 2021 Mar; 278(3):695-702. PubMed ID: 32844305
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Chemosensory disorders in Covid-19: Pathomechanisms and clinical relevance].
    Isenmann S; Haehner A; Hummel T
    Fortschr Neurol Psychiatr; 2021 Jun; 89(6):281-288. PubMed ID: 33621990
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Strategies for Evaluating Anosmia Therapeutics in the COVID-19 Era-Coming to Our Senses.
    Roland LT; Levy JM
    JAMA Otolaryngol Head Neck Surg; 2022 Sep; 148(9):837-839. PubMed ID: 35797021
    [No Abstract]   [Full Text] [Related]  

  • 47. Anosmia Is a Key Symptom of COVID-19 Infection and Should Be Used as a Diagnostic Tool.
    Lechien JR; Barillari MR; Jouffe L; Saussez S
    Ear Nose Throat J; 2020 Nov; 99(9):577-578. PubMed ID: 32436441
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Prevalence of Olfactory and Gustatory Dysfunction in COVID-19 Patients: A Systematic Review and Meta-analysis.
    Tong JY; Wong A; Zhu D; Fastenberg JH; Tham T
    Otolaryngol Head Neck Surg; 2020 Jul; 163(1):3-11. PubMed ID: 32369429
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Magnetic Resonance Imaging Alteration of the Brain in a Patient With Coronavirus Disease 2019 (COVID-19) and Anosmia.
    Politi LS; Salsano E; Grimaldi M
    JAMA Neurol; 2020 Aug; 77(8):1028-1029. PubMed ID: 32469400
    [No Abstract]   [Full Text] [Related]  

  • 50. Heralding Healthcare Professionals: Recognition of Neurological Deficits in COVID-19.
    Baig AM; Sanders EC
    ACS Chem Neurosci; 2020 Jun; 11(12):1701-1703. PubMed ID: 32469504
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Importance of Considering Olfactory Dysfunction During the COVID-19 Pandemic and in Clinical Practice.
    Desai M; Oppenheimer J
    J Allergy Clin Immunol Pract; 2021 Jan; 9(1):7-12. PubMed ID: 33130145
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Anosmia and hyposmia in health-care workers with undiagnosed SARS-CoV-2 infection.
    Lechner M; Counsell N; Liu J; Eynon-Lewis N; Paun S; Lund VJ; Jayaraj S; Philpott C
    Lancet Microbe; 2020 Aug; 1(4):e150. PubMed ID: 33521715
    [No Abstract]   [Full Text] [Related]  

  • 53. New onset of loss of smell or taste in household contacts of home-isolated SARS-CoV-2-positive subjects.
    Boscolo-Rizzo P; Borsetto D; Spinato G; Fabbris C; Menegaldo A; Gaudioso P; Nicolai P; Tirelli G; Da Mosto MC; Rigoli R; Polesel J; Hopkins C
    Eur Arch Otorhinolaryngol; 2020 Sep; 277(9):2637-2640. PubMed ID: 32449021
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Errors and Biases in Meta-analysis of the Prevalence of Olfactory Dysfunction in Patients With COVID-19.
    Santamaría-Gadea A; de Los Santos G; Alobid I; Mullol J; Mariño-Sánchez F
    Otolaryngol Head Neck Surg; 2021 Feb; 164(2):455-456. PubMed ID: 32777974
    [No Abstract]   [Full Text] [Related]  

  • 55. COVID-19 Anosmia: High Prevalence, Plural Neuropathogenic Mechanisms, and Scarce Neurotropism of SARS-CoV-2?
    Liang F; Wang Y
    Viruses; 2021 Nov; 13(11):. PubMed ID: 34835030
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Anosmia and COVID-19].
    Reinhard A; Ikonomidis C; Broome M; Gorostidi F
    Rev Med Suisse; 2020 Apr; 16(N° 691-2):849-851. PubMed ID: 32348051
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pleasant parosmia with regard to own stool after SARS-CoV-2 infection.
    Halabe-Cherem J; Salado-Burbano JC; Nellen-Hummel H
    Gac Med Mex; 2021; 157(6):636-638. PubMed ID: 35108257
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Decrease and Recovery of Olfactory and Gustatory Function in a Case of SARS-CoV-2 Infection.
    Liu DT; Prem B; Besser G; Mueller CA; Renner B
    ORL J Otorhinolaryngol Relat Spec; 2021; 83(2):130-134. PubMed ID: 33264790
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Objective evaluation of odor loss in COVID-19 and other suspected cases.
    Seden N; Yiğit E; Yiğit Ö; Kaygısız İ
    Am J Otolaryngol; 2021; 42(1):102761. PubMed ID: 33080550
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Regarding Use of Topical Steroids in Patients With COVID-19-Associated Olfactory Loss-Reply.
    Levy JM
    JAMA Otolaryngol Head Neck Surg; 2021 Jan; 147(1):110-111. PubMed ID: 33211079
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.